MELANOMA BRIDGE
December 3rd - December 5th, 2020
VIRTUAL MEETING



Presidents


Paolo A. Ascierto

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy



Corrado Caracò

Corrado Caracò
Chief of Surgery of Melanoma and Skin Cancer Unit, Dept of Haematology and Developmental Therapeutics, National Cancer Institute "Fondazione Pascale", Naples, Italy



Iman Osman

Iman Osman
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York, US



Igor Puzanov

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, New York, USA





Scientific Board


Sanjiv Agarwala

Sanjiv Agarwala
Professor & Chief, Haematology & Oncology, St Luke's University Hospital and Temple University, Bethlehem, Pennsylvania, US



Paolo A. Ascierto

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy



Carlo Bifulco

Carlo Bifulco
Medical Director of Oncological Molecular Pathology and Pathology Informatics, Providence Oregon Regional Laboratory and Earle A. Chiles Research Institute, Portland, Oregon, US



Elizabeth Burton

Elizabeth Burton
Director, Melanoma Research Planning & Development, The University of Texas MD Anderson Cancer Center, Houston, TX, US



Lisa H. Butterfield

Lisa H. Butterfield
Research Center Vice President, Parker Institute for Cancer Immunotherapy and Adjunct Professor of Microbiology and Immunology, University of California, San Francisco, California, US



Corrado Caracò

Corrado Caracò
Chief of Surgery of Melanoma and Skin Cancer Unit, Dept of Haematology and Developmental Therapeutics, National Cancer Institute "Fondazione Pascale", Naples, Italy



Sandra Demaria

Sandra Demaria
Department of radiation oncology and pathology and laboratory medicine, Weill Cornell Medicine, New York, New York, US


Reinhard Dummer

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland



Bernard A. Fox

Bernard A. Fox
Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, Oregon, US



Jerome Galon

Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Paris, France




Claus Garbe

Claus Garbe
Professor of Dermatology, Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany



Omid Hamid

Omid Hamid
Chief of Research/ Immuno-Oncology and Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, Los Angeles, California, US



Giuseppe Masucci

Giuseppe Masucci
Professor, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden



Iman Osman

Iman Osman
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York, US



Giuseppe Palmieri

Giuseppe Palmieri
President Italian Melanoma Intergroup (IMI), Head of Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy



Michael Postow

Michael Postow
Memorial Sloane Kettering Cancer Center, New York City, New York, USA




Igor Puzanov

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, New York, USA


Magdalena Thurin

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland, USA



Tara Withington

Tara Withington
Executive Director of Society of Immunotherapy for Cancer (SITC), Milwaukee, Wisconsin, USA




 


For information please contact info@melanomabridge.org